Drugs Made In America Acquisition Corp. (DMAA)
Nasdaq: DMAA · Blank Checks · filing with the SEC since 2024
Who owns Drugs Made In America Acquisition Corp.
As filed with the SECHolders of 5% or more
5
Drugs Made In America Acquisition LLC holds 12.5% of Ordinary Shares, as its SCHEDULE 13D filed Mar 3, 2025 says.
Directors and officers
n/a
The record holds no Form 3, 4 or 5 for this company yet.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Drugs Made In America Acquisition LLC
SCHEDULE 13D · filed Mar 3, 2025 · Ordinary Shares
Karpus Management, Inc.
SCHEDULE 13G/A · filed Aug 14, 2026 · Common · 8.19% in Aug 14, 2025
Mizuho Financial Group, Inc.
SCHEDULE 13G/A · filed Aug 13, 2026 · Common Shares · 6% in May 14, 2026
Polar Asset Management Partners Inc.
SCHEDULE 13G · filed May 15, 2025 · Ordinary Shares
Feis Equities LLC
SCHEDULE 13G · filed Jun 26, 2026 · Ordinary share ($0.0001 par value)
Hudson Bay Capital Management LP
SCHEDULE 13G/A · filed Nov 12, 2025 · Ordinary Shares, $0.0001 par value · reported falling below 5%, from 5.37% in May 14, 2025
Glazer Capital, LLC
SCHEDULE 13G/A · filed Aug 13, 2026 · Ordinary Shares · reported falling below 5%, from 5.44% in May 15, 2025
First Trust Capital Management L.P.
SCHEDULE 13G/A · filed Aug 14, 2026 · Class A Ordinary Shares, par value $0.0001 per share ("Ordinary Shares") · reported falling below 5%, from 6.17% in May 15, 2025
What DMAA reports owning in othersstakes of 5% or more, and other ties
Drugs Made In America Acquisition Corp. reports no stake in another company in the record.
Insider tradesForm 4
The record holds no insider filings for this company yet.